申请人:——
公开号:US20030166646A1
公开(公告)日:2003-09-04
The present invention relates to the use of 2-amino-thiazoline derivatives of formula (I):
1
in which either Y is a methylene (CH
2
) and X is chosen from the following groups: O, NH, (C1-C4) N-Alkyl, N-Bn, N-Ph, N-(2-Py), N-(3-Py), N-(4-Py), N-2-pyrimidyl, N-5-pyrimidyl, S, SO, SO
2
, CH
2
or CHPh; or Y is a carbonyl (C═O) and X is chosen from the following groups: NH, N-Ph, N-(2-Py), N-(3-Py), N-(4-Py), N-2-pyrimidyl or N-5-pyrimidyl or pharmaceutically acceptable salts thereof as inhibitors of inducible NO-synthase.
本发明涉及使用式(I)的2-氨基噻唑衍生物,其中Y为亚甲基(CH2),并且X选自以下基团:O,NH,(C1-C4)N-烷基,N-Bn,N-Ph,N-(2-Py),N-(3-Py),N-(4-Py),N-2-嘧啶基,N-5-嘧啶基,S,SO,SO2,CH2或CHPh;或者Y为羰基(C=O),并且X选自以下基团:NH,N-Ph,N-(2-Py),N-(3-Py),N-(4-Py),N-2-嘧啶基或N-5-嘧啶基,或其药学上可接受的盐,作为诱导型一氧化氮合酶的抑制剂。